Tumor vessel development and expansion in Ewing's sarcoma: A review of the vasculogenesis process and clinical trials with vascular-targeting agents

Sarcoma

Volumn 2011, Issue , 2011, Pages

  Kleinerman, Eugenie S ^a   Stewart, Keri S ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; ANTINEOPLASTIC METAL COMPLEX; BEVACIZUMAB; CD34 ANTIBODY; DELTA LIKE LIGAND 4; DESMIN; GREEN FLUORESCENT PROTEIN; NOTCH RECEPTOR; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; STROMAL CELL DERIVED FACTOR 1ALPHA; TAXANE DERIVATIVE; UNCLASSIFIED DRUG; VASCULAR TARGETING AGENT; VASCULOTROPIN;

ABSENCE OF SIDE EFFECTS; ANGIOGENESIS; BONE MARROW CELL; CANCER CHEMOTHERAPY; CELL DIFFERENTIATION; CELL POPULATION; CHEMOTAXIS; CHILDHOOD MORTALITY; COLORECTAL CANCER; DRUG APPROVAL; DRUG EFFICACY; DRUG SAFETY; DRUG TARGETING; ENDOTHELIUM CELL; EWING SARCOMA; GLIOBLASTOMA; HUMAN; INCIDENCE; LUNG METASTASIS; MACROPHAGE; MONOCYTE; NONHUMAN; PERICYTE; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; STEM CELL; TUMOR GROWTH; TUMOR XENOGRAFT; VASCULAR SMOOTH MUSCLE;

EID: 80052676849     PISSN: 1357714X     EISSN: 13691643     Source Type: Journal    
DOI: 10.1155/2011/165837     Document Type: Review

References (42)

1. Subbiah V., Anderson P., Lazar A., Burdett E., Raymond K., Ludwig J., Ewing's sarcoma: standard and experimental treatment options Current Treatment Options in Oncology 2009 10 1-2 126 140
2. Yock T., Krailo M., Fryer C., Donaldson S., Miser J. S., Chen Z., Bernstein M., Laurie F., Gebhardt M. C., Grier H. E., Tarbell N. J., Local control in pelvic Ewing sarcoma: analysis from INT-0091a report from the children's oncology group Journal of Clinical Oncology 2006 24 24 3838 3843 (Pubitemid 46655603)
3. Anderson P., Kopp L., Anderson N., Cornelius K., Herzog C., Hughes D., Huh W., Novel bone cancer drugs: investigational agents and control paradigms for primary bone sarcomas (Ewing's sarcoma and osteosarcoma) Expert Opinion on Investigational Drugs 2008 17 11 1703 1715
4. Wexler L. H., DeLaney T. F., Tsokos M., Avila N., Steinberg S. M., Weaver-McClure L., Jacobson J., Jarosinski P., Hijazi Y. M., Balis F. M., Horowitz M. E., Ifosfamide and etoposide plus vincristine, doxorubicin, and cyclophosphamide for newly diagnosed Ewing's sarcoma family of tumors Cancer 1996 78 4 901 911 (Pubitemid 26268624)
5. Granowetter L., Womer R., Devidas M., Krailo M., Wang C., Bernstein M., Marina N., Leavey P., Gebhardt M., Healey J., Shamberger R. C., Goorin A., Miser J., Meyer J., Arndt C. A. S., Sailer S., Marcus K., Perlman E., Dickman P., Grier H. E., Dose-intensified compared with standard chemotherapy for nonmetastatic Ewing sarcoma family of tumors: A Children's Oncology Group Study Journal of Clinical Oncology 2009 27 15 2536 2541
6. Womer R. B., West D. C., Krailo M. D., Dickman P. S., Pawel B., Trial of chemotherapy intensification through interval compression in Ewing's sarcoma and related tumors children's oncology group AEWS0031 Journal of Clinical Oncology 2008 26 supplement. abstract no. 10504
7. Hanahan D., Weinberg R. A., The hallmarks of cancer Cell 2000 100 1 57 70 (Pubitemid 30046295)
8. Folkman J., Angiogenesis Annual Review of Medicine 2006 57 1 18 (Pubitemid 43261975)
9. Dimmeler S., Regulation of bone marrow-derived vascular progenitor cell mobilization and maintenance Arteriosclerosis, Thrombosis, and Vascular Biology 2010 30 6 1088 1093
10. Asahara T., Takahashi T., Masuda H., Kalka C., Chen D., Iwaguro H., Inai Y., Silver M., Isner J. M., VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells EMBO Journal 1999 18 14 3964 3972 (Pubitemid 29335849)
11. Amin A. H., Abd Elmageed Z. Y., Nair D., Partyka M. I., Kadowitz P. J., Belmadani S., Matrougui K., Modified multipotent stromal cells with epidermal growth factor restore vasculogenesis and blood flow in ischemic hind-limb of type II diabetic mice Laboratory Investigation 2010 90 7 985 996
12. Wu Y., Zhao R. C. H., Tredget E. E., Concise review: bone marrow-derived stem/progenitor cells in cutaneous repair and regeneration Stem Cells 2010 28 5 905 915
13. Ribatti D., Postnatal vasculogenesis Mechanisms of Development 2001 100 2 157 163 (Pubitemid 32109326)
14. Bolontrade M. F., Zhou R., Kleinerman E. S., Vasculogenesis plays a role in the growth of Ewing's sarcoma in vivo Clinical Cancer Research 2002 8 11 3622 3627 (Pubitemid 35340741)
15. Reddy K., Cao Y., Zhou Z., Yu L., Jia S. F., Kleinerman E., VEGF 165 expression in the tumor microenvironment influences the differentiation of bone marrow-derived pericytes that contribute to the Ewing's sarcoma vasculature Angiogenesis 2008 11 3 257 267
16. Reddy K., Zhou Z., Schadler K., Jia S. F., Kleinerman E. S., Bone marrow subsets differentiate into endothelial cells and pericytes contributing to Ewing's tumor vessels Molecular Cancer Research 2008 6 6 929 936
17. Schadler K., Zweidler-McKay P., Guan H., Kleinerman E., Delta-like ligand 4 plays a critical role in pericyte/vascular smooth muscle cell formation during vasculogenesis and tumor vessel expansion in Ewing's sarcoma Clinical Cancer Research 2010 16 3 848 856
18. Zhou Z., Sv K., Jia S. F., Yu L., Kleinerman E. S., Bone marrow cells participate in tumor vessel formation in lung metastatic tumors of Ewing's sarcoma [Abstract] Proceedings of the American Association for Cancer Research 100th Annual Meeting 2009 Denver, Colo
19. Coffelt S. B., Hughes R., Lewis C. E., Tumor-associated macrophages: effectors of angiogenesis and tumor progression Biochimica et Biophysica Acta 2009 1796 1 11 18
20. Ferrara N., Role of myeloid cells in vascular endothelial growth factor-independent tumor angiogenesis Current Opinion in Hematology 2010 17 3 219 224
21. Yu L., Su B., Hollomon M., Deng Y., Facchinetti V., Kleinerman E. S., Vasculogenesis driven by bone marrow-derived cells is essential for growth of Ewing's sarcomas Cancer Research 2010 70 4 1334 1343
22. Zhou Z., Reddy K., Guan H., Kleinerman E. S., VEGF, but not VEGF, stimulates vasculogenesis and bone marrow cell migration into Ewing's sarcoma tumors in vivo Molecular Cancer Research 2007 5 11 1125 1132 (Pubitemid 350137108)
23. Guan H., Zhou Z., Wang H., Jia S. F., Liu W., Kleinerman E. S., A small interfering RNA targeting vascular endothelial growth factor inhibits Ewing's sarcoma growth in a xenograft mouse model Clinical Cancer Research 2005 11 7 2662 2669 (Pubitemid 40569467)
24. Dalal S., Berry A. M., Cullinane C. J., Mangham D. C., Grimer R., Lewis I. J., Johnston C., Laurence V., Burchill S. A., Vascular endothelial growth factor: a therapeutic target for tumors of the Ewing's sarcoma Family Clinical Cancer Research 2005 11 6 2364 2378 (Pubitemid 40490198)
25. Lee T. H., Bolontrade M., Worth L. L., Guan H., Ellis L. M., Kleinerman E. S., Production of VEGF165 by Ewing's sarcoma cells induces vasculogenesis and the incorporation of CD34+ stem cells into the expanding tumor vasculature International Journal of Cancer 2006 119 4 839 846 (Pubitemid 44051447)
26. Zhou Z., Bolontrade M., Reddy K., Duan X., Guan H., Yu L., Hicklin D. J., Kleinerman E. S., Suppression of Ewing's sarcoma tumor growth, tumor vessel formation, and vasculogenesis following anti-vascular endothelial growth factor receptor-2 therapy Clinical Cancer Research 2007 13 16 4867 4873 (Pubitemid 47294794)
27. Reddy K., Zhou Z., Jia S. F., Lee T. H., Morales-Arias J., Cao Y., Kleinerman E. S., Stromal cell-derived factor-1 stimulates vasculogenesis and enhances Ewing's sarcoma tumor growth in the absence of vascular endothelial growth factor International Journal of Cancer 2008 123 4 831 837 (Pubitemid 352032409)
28. Daz-Flores L., Gutiérrez R., Madrid J. F., Varela H., Valladares F., Acosta E., Martn-Vasallo P., Daz-Flores L., Pericytes. Morphofunction, interactions and pathology in a quiescent and activated mesenchymal cell niche Histology and Histopathology 2009 24 7 909 969
29. Rensen S. S., Doevendans P., Van Eys G. J., Regulation and characteristics of vascular smooth muscle cell phenotypic diversity Netherlands Heart Journal 2007 15 3 100 108 (Pubitemid 47253691)
30. Hirschi K., Rohovsky S., D'Amore P., PDGF, TGF-b, and heterotypic cell-cell interactions mediate endothelial cell-induced recruitment of 10T1/2 cells and their differentiation to a smooth muscle fate Journal of Cell Biology 1998 141 3 805 814 (Pubitemid 28217923)
31. Bergers G., Song S., The role of pericytes in blood-vessel formation and maintenance Neuro-Oncology 2005 7 4 452 464 (Pubitemid 41555617)
32. Von Tell D., Armulik A., Betsholtz C., Pericytes and vascular stability Experimental Cell Research 2006 312 5 623 629 (Pubitemid 43290338)
33. Fiza U. M., Arias A. M., Cell and molecular biology of notch Journal of Endocrinology 2007 194 3 459 474 (Pubitemid 47471215)
34. Fortini M. E., Notch signaling: the core pathway and its posttranslational regulation Developmental Cell 2009 16 5 633 647
35. Schadler K. L., Zweidler-McKay P. A., Guan H., Kleinerman E. S., Delta-like ligand 4 plays a critical role in pericyte/vascular smooth muscle cell formation during vasculogenesis and tumor vessel expansion in Ewing's sarcoma Clinical Cancer Research 2010 16 3 848 856
36. Schadler K., Zweidler-McKay P., Kleinerman E., The role of DLL4-notch signaling in bone marrow cell differentiation into pericytes Proceedings of the Keystone Symposia: Angiogenesis and Lymphangiogenesis in Cancer 2009 Big Sky, Mont, USA
37. Bender J. L. G., Adamson P. C., Reid J. M., Xu L., Baruchel S., Shaked Y., Kerbel R. S., Cooney-Qualter E. M., Stempak D., Chen H. X., Nelson M. D., Krailo M. D., Ingle A. M., Blaney S. M., Kandel J. J., Yamashiro D. J., Phase I trial and pharmacokinetic study of bevacizumab in pediatric patients with refractory solid tumors: a Children's Oncology Group study Journal of Clinical Oncology 2008 26 3 399 405 (Pubitemid 351171691)
38. Ranpura V., Hapani S., Wu S., Treatment-related mortality with bevacizumab in cancer patients Journal of the American Medical Association 2011 305 5 487 494
39. DuBois S. G., Marina N., Glade-Bender J., Angiogenesis and vascular targeting in Ewing sarcoma: a review of preclinical and clinical data Cancer 2010 116 3 749 757
40. Huang J., Frischer J. S., Serur A., Kadenhe A., Yokoi A., McCrudden K. W., New T., O'Toole K., Zabski S., Rudge J. S., Holash J., Yancopoulos G. D., Yamashiro D. J., Kandel J. J., Regression of established tumors and metastases by potent vascular endothelial growth factor blockade Proceedings of the National Academy of Sciences of the United States of America 2003 100 13 7785 7790 (Pubitemid 36760047)
41. De Bock K., Cauwenberghs S., Carmeliet P., Vessel abnormalization: another hallmark of cancer? Molecular mechanisms and therapeutic implications Current Opinions in Genetics and Development 2011 21 73 79
42. Shaked Y., Kerbel R. S., Antiangiogenic strategies on defense: on the possibility of blocking rebounds by the tumor vasculature after chemotherapy Cancer Research 2007 67 15 7055 7058 (Pubitemid 47206528)